Google launches a blind AI tool
Google is doing one of the most important things right now with the largest medical company, launching an electronic AI tool that will help consumers identify their skin.
Derm assist is the first of its kind and has been launched in Europe this year before preparing for about 2bn people worldwide who have skin problems ranging from acne to skin cancer.
Users post their medical photos via the Derm Assist page and answer questions about their identification. AI model analyzes the data and compiles a list of similarities. This service is free to all internet users, whether they are Google users or not.
“This tool is not designed to infect you…. Instead, we believe it gives you the opportunity to get reliable information so that you can make informed choices about what to do,” Google said.
The launch follows three years of growth at Google, which has long seen medical care as a market to be disrupted by advanced intelligence. It comes at a time when rivals Apple, Amazon and Microsoft are also pushing for access to lucrative positions, and to provide medical care to consumers, physicians and medical companies.
Google chose dermatology as the first target of AI-based medical care due to the large number of people affected by the skin. Approximately 10bn Google searches occur each year in terms of skin, nails and hair, and research has shown that people find themselves 13% of the time, the search giant said.
“Skin diseases as a group are one of the most difficult assets in the world – people are turning to Google to find out their skin problems. Most diseases are cured, but half of the world’s population suffers from dermatologists,” said Dr Peggy Bui, manager. is a saleswoman at Google Health and a medical specialist at the University of California, San Francisco.
The derm assist system was set up with machine learning systems in over 16,000 cases worldwide. According to research since last year, the tool is able to diagnose the skin as accurately as US licensed dermatologists.
Some of the information provided to users is reviewed by medical professionals. When a user experiences any danger signs, such as shortness of breath, additional medications are recommended to see a doctor immediately.
Lesson published in the JAMA Network Open found that the AI tool also significantly contributed to the accuracy of non-professionals such as GPs and physicians, who used them to help them identify skin.
“Our findings suggest that AI has the potential to increase the potential for[generalist doctors and nurses]. . . to detect and cleanse the skin more carefully, “wrote study author Yuan Liu and his team in a peer-reviewed paper.” Improving the accuracy of undiagnosed cases… can have significant implications for health services. ”
Eric Topol, professor of molecular biology at the Scripps Research Institute, as well as an expert on AI and medicine, said: “This has to happen at some point, because it was the first major AI training program for effective drug use in 2017.”
In order to prevent the development of skin cancer through malignancies, algorithms were developed to be more prudent in making decisions. “When we did this, we said we wanted to stimulate a lot of interest, especially dangerous or dangerous,” said Dr Bui.
In an effort to address privacy issues regarding user health, Google said it would not use images that were uploaded to advertising, and could only store images to help promote Derm Assist, if readers give them explicit permission.
“Users have control over their content and the opportunity to save, delete or provide research,” said Dr Bui. “We hope to strengthen the offerings, as the algorithms are the same as what they were taught. . . We will continue to improve this model by analyzing other data from other sources, in addition to the data provided. “